Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2025

FAIR VALUE OF FINANCIAL INSTRUMENTS

Schedule of Fair Value Instruments

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and December 31, 2024 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine the fair value (in thousands):

	December 31, 2025
	Level 1		Level 2		Level 3		Total
Cash equivalents:
Money market funds	$	87,989	$	—	$	—	$	87,989
Current investments:						—
U.S. treasury securities		—		54,927		—		54,927
U.S. government-sponsored agency securities		14,024		47,290		—		61,314
Commercial paper		—		8,907		—		8,907
Corporate debt securities		109,075		13,497		—		122,572
Total	$	211,088	$	124,621	$	—	$	335,709

	December 31, 2024
	Level 1		Level 2		Level 3		Total
Assets
Money market fund	$	65,000	$	—	$	—	$	65,000
Total assets	$	65,000	$	—	$	—	$	65,000
Liabilities
Convertible notes payable, noncurrent	$	—	$	—	$	107,600	$	107,600
Total liabilities	$	—	$	—	$	107,600	$	107,600

Summary of Changes in The Fair Value of Level 3

The following table presents the changes in the fair value of the Level 3 Convertible Notes payable (in thousands):

	Amounts
Balance as of June 18, 2024	$	—
Convertible Notes payable issuance		95,000
Change in fair value of Convertible Notes payable		12,600
Balance as of December 31, 2024		107,600
Change in fair value of Convertible Notes payable		21,584
Conversion of convertible notes into common stock and pre-funded warrants upon the Closing		(129,184	)
Balance as of December 31, 2025	$	—

Schedule of Assumptions Related to The Change in Fair Value

The following table presents the significant assumptions related to the change in fair value for the year ended December 31, 2024:

Time from Convertible Notes issuance to Next Equity Financing (in years)	0.58 - 0.77
Probability of Next Equity Financing		90.0	%
Time from Convertible Notes issuance to Next Equity Financing / prior to trade sale (in years)	0.75 - 0.93
Probability of Next Equity Financing / prior to trade sale		10.0	%
Interest rate		12.0	%
Discount rate		67.0	%